Skip to main content
. Author manuscript; available in PMC: 2018 Aug 21.
Published in final edited form as: Leukemia. 2018 Feb 21;32(6):1421–1426. doi: 10.1038/s41375-018-0063-7

Figure 1.

Figure 1

Overall Survival based on presence of clonal circulating plasma cells (a) all newly diagnosed AL amyloidosis patients and (b) newly diagnosed AL amyloidosis patients, excluding those with CRAB features

Shown is overall survival based on presence or absence of cPCs at diagnosis in patients with light chain amyloidosis

1, 2 and 5 year overall survival rates based on presence of cPCs were:

a: cPCs present: 74%, 64% and 57%

cPCs absent: 89%, 87% and 80%

b: cPCs present: 76%, 67% and 63%

cPCs absent: 90%, 89% and 82%